Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004984150 | SCV005613632 | uncertain significance | Inborn genetic diseases | 2024-10-01 | criteria provided, single submitter | clinical testing | The c.262C>A (p.Q88K) alteration is located in exon 3 (coding exon 3) of the KMT2C gene. This alteration results from a C to A substitution at nucleotide position 262, causing the glutamine (Q) at amino acid position 88 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |